Pulse Biosciences Inc
NASDAQ:PLSE
Pulse Biosciences Inc
NASDAQ:PLSE
Price:
7.19 USD
7.47%
Updated:
Apr 29, 2024
Pulse Biosciences Inc
Cash from Financing Activities
|
Pulse Biosciences Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pulse Biosciences Inc
NASDAQ:PLSE
|
Cash from Financing Activities
$16.4m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-425%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Pulse Biosciences Inc's Cash from Financing Activities?
Cash from Financing Activities
16.4m
USD
16.4m
USD
Based on the financial report for Dec 31, 2023, Pulse Biosciences Inc's Cash from Financing Activities amounts to 16.4m USD.
What is Pulse Biosciences Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-18%
-18%
Over the last year, the Cash from Financing Activities growth was -79%. The average annual Cash from Financing Activities growth rates for Pulse Biosciences Inc have been -19% over the past three years , -18% over the past five years .
You don't have any saved screeners yet
